Evidence map›Paper›PMID 26804484›Full record

Trial reportClinical & experimental optometry2016

An analysis of observer-rated functional vision in patients implanted with the Argus II Retinal Prosthesis System at three years.

Duane R Geruschat, Thomas P Richards, Aries Arditi, Lyndon da Cruz, Gislin Dagnelie, Jessy D Dorn, Jacque L Duncan, Allen C Ho, Lisa C Olmos de Koo, José-Alain Sahel and 4 more

Abstract readClinical Trial
In one paragraph

Trial report in Clinical & experimental optometry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Review
  7. Review
  8. Article
  9. Article
  10. Restoration of Sight with Electronic Retinal Prostheses.Annual review of vision science · 2025
    Review
  11. Article
  12. Static or Temporal? Semantic Scene Simplification to Aid Wayfinding in Immersive Simulations of Bionic Vision.Proceedings of the ACM Symposium on Virtual Reality Software and Technology. ACM Symposium on Virtual Reality Software and Technology · 2025
    Article
  13. Aligning Visual Prosthetic Development With Implantee Needs.Translational vision science & technology · 2024
    Article
  14. Aligning visual prosthetic development with implantee needs.medRxiv : the preprint server for health sciences · 2024
    Article
  15. Article
  16. Bioengineering strategies for restoring vision.Nature biomedical engineering · 2023
    Review
  17. Article
  18. Towards aJournal of neural engineering · 2022
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Duane R GeruschatWilmer Eye Institute, Johns Hopkins University, Baltimore, Maryland, USA.
Thomas P RichardsIM3 Inc, Vancouver, Washington, USA. tomami20x@gmail.com.
Aries ArditiLighthouse Guild International, New York, New York, USA.
Lyndon da CruzMoorfields Eye Hospital, London, United Kingdom.
Gislin DagnelieLions Vision Research and Rehab Center, Johns Hopkins University, Baltimore, Maryland, USA.
Jessy D DornSecond Sight Medical Products, Sylmar, California, USA.
Jacque L DuncanUniversity of California San Francisco, San Francisco, California, USA.
Allen C HoWills Eye Hospital, Philadelphia, Pennsylvania, USA.
Lisa C Olmos de KooUniversity of Southern California, Los Angeles, California, USA.
José-Alain SahelCentre Hospitalier National d'Ophtalmologie des Quinze-Vingts, Paris, France.
Paulo E StangaManchester Royal Eye Hospital, Manchester, United Kingdom.
Gabriele ThumannHôpitaux Universitaires de Genève, Geneva, Switzerland.
Vizhong WangRetina Foundation of the Southwest, Dallas, Texas, USA.
Robert J GreenbergSecond Sight Medical Products, Sylmar, California, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe purpose of this analysis was to compare observer-rated tasks in patients implanted with the Argus II Retinal Prosthesis System, when the device is ON versus OFF.

methodsThe Functional Low-Vision Observer Rated Assessment (FLORA) instrument was administered to 26 blind patients implanted with the Argus II Retinal Prosthesis System at a mean follow-up of 36 months. FLORA is a multi-component instrument that consists in part of observer-rated assessment of 35 tasks completed with the device ON versus OFF. The ease with which a patient completes a task is scored using a four-point scale, ranging from easy (score of 1) to impossible (score of 4). The tasks are evaluated individually and organised into four discrete domains, including 'Visual orientation', 'Visual mobility', 'Daily life and 'Interaction with others'.

resultsTwenty-six patients completed each of the 35 tasks. Overall, 24 out of 35 tasks (69 per cent) were statistically significantly easier to achieve with the device ON versus OFF. In each of the four domains, patients' performances were significantly better (p < 0.05) with the device ON versus OFF, ranging from 19 to 38 per cent improvement.

conclusionPatients with an Argus II Retinal Prosthesis implanted for 18 to 44 months (mean 36 months), demonstrated significantly improved completion of vision-related tasks with the device ON versus OFF.

Indexed as

Vision, OcularVisual ProsthesisHumansProsthesis ImplantationArgus IIFLORAfunctional visionretinal prosthesisretinitis pigmentosa

Identifiers

PMID26804484
PMCPMC5066820

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.